Using distributional cost effectiveness analysis to reduce health inequality
Distributional cost-effectiveness analysis of gene therapy vs SOC in patients with SCD in the US
Cost Effectiveness Models Explained: Which One is Right for Your Analysis?
Distributional Cost-Effectiveness Analysis (DCEA)
Cost Effectiveness Analysis: An Introduction
Distributive & Extended Cost Effectiveness Analyses—DCEA & ECEA by Prof. Kjell Arne Johansson (UiB)
Challenges and Limitations in Distributional Cost-Effectiveness Analysis
Quantifying and Valuing Health Inequality Impacts in Economic Evaluation
NEJM Interview: Dr. Ankur Pandya on rigorously assessing the costs and benefits of various policy...
HTAsiaLink Webinar 1 | Cost-effectiveness Thresholds and Decision-making in Healthcare
Natalie Carvalho - Cost-Effectiveness Analysis @ EAGxAustralia 2018
An Evidence Based Approach to CADTH’s Cost-Effectiveness Threshold
Equity Considerations in Economic Evaluation - Ageing Research - ARC Shared Learning Event May 2022
SGO 2021 Virtual Annual Meeting: A Cost-effectiveness Analysis
Barriers to integrating cost-effectiveness analysis & cost-benefit analysis into impact evaluations
iHEA Basel Congress - July 17 - Special Organized Session: Health Equity Economic Evaluations
Limitations of QALYs in Cost-Effectiveness Reviews for Rare Disease Drugs
Meetup #14 - Chair: Sally Davies
CHEERS to Economic Evaluation Reporting
Experts Discuss How Expanding Traditional Value Frameworks Can Address Inequities in Health Outcomes
